MedPath

Active Breaks in People With Type 1 Diabetes

Not Applicable
Recruiting
Conditions
Type 1 Diabetes
Interventions
Behavioral: Active Breaks
Registration Number
NCT05706298
Lead Sponsor
Liverpool John Moores University
Brief Summary

the investigators aim to determine the effect of 4 weeks of frequent active breaks from prolonged sitting on time in target glycaemic range in people with type 1 diabetes with high habitual sedentary behaviour.

Detailed Description

An open-label randomised controlled trial, whereby participants will complete pre-randomisation baseline procedures before allocation to 4wks of habitual activity (control) or active breaks. Interstitial glucose concentrations (fGM), insulin dose and physical activity/ postural transitions (ActivPAL) will be monitored throughout. To improve generalisability and feasibility of recruiting the required number of participants, the study will be completed in a free-living environment using remote data collection methods.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
118
Inclusion Criteria
  • T1D diagnosis more than 3 years ago
  • Sedentary (> 10h per waking day sedentary (sitting or lying)
  • Using insulin therapy with multiple daily injections or insulin pump
  • Aged 18-66 (UK retirement age)
  • Use of Abbot FreeStyle Libre 2 fGM (>6 weeks to avoid potential lifestyle changes as a result of sensor use)
Exclusion Criteria
  • Engaged in structured planned exercise (e.g. running, cycling, gym, or sports)
  • Pregnancy or planning to become pregnant
  • <6 months postpartum or stopped breastfeeding <1 month before recruitment
  • Existing cerebrovascular or cardiovascular disease
  • Significant history of hyperglycaemia (HbA1c >85 mmol/mol)
  • History of severe hypoglycaemia requiring third party assistance within the last 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active breaksActive BreaksParticipants will be asked to interrupt sitting with 3 min bouts of walking every 30 min (16 bouts per day, equalling 48 min of walking) from 9am-5pm every day throughout the 4 week period. To improve adherence should participants miss a bout of walking they will be asked to do 6 min during the next bout.
Primary Outcome Measures
NameTimeMethod
Change in time in target glycaemic rangechange from baseline to final week of the intervention

flash glucose monitoring

Secondary Outcome Measures
NameTimeMethod
c-peptidebaseline

c-peptide

Change in insulin dosechange from baseline to final week of the intervention

Insulin dose

Change in glycaemic variability (coefficient of variation)change from baseline to final week of the intervention

flash glucose monitoring

Change in Concentration of Hba1cchange from baseline to post intervention (4 weeks)

HbA1c

Change in weightchange from baseline to post intervention (4 weeks)

weight (kg)

Change in BMIchange from baseline to post intervention (4 weeks)

BMI

Change in waist circumferencechange from baseline to post intervention (4 weeks)

waist circumference (cm)

Change in sedentary behaviourchange from baseline to final week of the intervention

minutes of sitting

Change in Health-related quality of lifechange from baseline to post intervention (4 weeks)

Short Form-12 Health Survey (SF-12)

Change in Anxiety and depressionchange from baseline to post intervention (4 weeks)

The Hospital Anxiety and Depression Scale (HADS)

Change in carbohydrate intakechange from baseline to final week of the intervention

carbohydrate intake

Change in Heightchange from baseline to post intervention (4 weeks)

Height (cm)

Change Insulin to CHO ratiochange from baseline to post intervention (4 weeks)

Insulin to CHO ratio

Change in Diabetes Quality of Lifechange from baseline to post intervention (4 weeks)

Diabetes Quality of Life (DQOL) questionnaire

Change in triglycerides.change from baseline to post intervention (4 weeks)

triglycerides.

Change in Insulin Sensitivity Scorechange from baseline to post intervention (4 weeks)

LogeIS

Trial Locations

Locations (1)

Liverpool John Moores University

🇬🇧

Liverpool, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath